TARGET: Acute Lymphoblastic Leukemia (ALL) Expansion Phase 2
Demographics (2)
- AGE_AT_DIAGNOSIS - Age at diagnosis, rounded to the nearest year (phv00167585.v13.p8)
- GENDER - Gender (phv00167582.v14.p8)
Race and Ethnicity (2)
- ETHNICITY - NAACCR Ethnicity (phv00167584.v13.p8)
- RACE - NAACCR Race (phv00167583.v13.p8)
Other (20)
- ANALYTETYPE - Analyte type (phv00167603.v17.p8)
- BCR_ABL_STATUS - BCR ABL Status (phv00167598.v13.p8)
- CNS_STATUS_AT_DIAGNOSIS - CNS status at diagnosis (phv00167587.v13.p8)
- DISEASEPROJECT - Disease project (phv00196455.v12.p8)
- DISEASESTATE - Disease state of sample (phv00167600.v17.p8)
- E2A_PBX1_STATUS - E2A PBX1 Status (phv00167597.v13.p8)
- EXTRACTNAME - Extract name (phv00167601.v17.p8)
- FIRST_EVENT - First Event (phv00167591.v13.p8)
- MLL_STATUS - MLL Status (phv00167596.v13.p8)
- MRD_DAY29 - Minimum residual disease status, in blood, day 29, 0.01% sensitivity (phv00167590.v13.p8)
- MRD_DAY8 - Minimum residual disease status, in blood, day 8, 0.01% sensitivity (phv00167589.v13.p8)
- SAMPLENAME - Sample Name (phv00167599.v17.p8)
- SAMPLETYPE - Sample type (phv00167602.v17.p8)
- SUBJID - TARGET Subject id (phv00167581.v13.p8)
- TESTICULAR_INVOLVEMENT - Testicular disease status at diagnosis (phv00167588.v13.p8)
- TRISOMIES_4_10_STATUS - Trisomes 4 10 Status (phv00167595.v13.p8)
- VITAL_STATUS - Vital Status (phv00167593.v13.p8)
- WBC_AT_DIAGNOSIS - White Blood Cell Range at diagnosis (phv00167586.v13.p8)
- YEARS_TO_DEATH - Time to death, rounded to nearest 0.25 years (phv00167594.v13.p8)
- YEARS_TO_EVENT - Time to first event (or censoring), rounded to nearest 0.25 years (phv00167592.v13.p8)